{
    "2020-12-14": [
        [
            {
                "time": "2021-03-01",
                "original_text": "How one influential billionaire thinks Trump messed up the COVID-19 response",
                "features": {
                    "keywords": [
                        "billionaire",
                        "Trump",
                        "COVID-19",
                        "response"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Should the U.S. Have Bought More Doses of Pfizer's COVID Vaccine?",
                "features": {
                    "keywords": [
                        "U.S.",
                        "Pfizer",
                        "COVID",
                        "vaccine",
                        "doses"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "AstraZenecaâ€™s $39 Billion Takeout of Alexion Wins Tepid Wall Street Approval",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Alexion",
                        "acquisition",
                        "Wall Street"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Unusual Options Activity Insight: Johnson & Johnson",
                "features": {
                    "keywords": [
                        "options",
                        "activity",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Coronavirus update: First Pfizer vaccine shots, U.K. to start human challenge trials",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Pfizer",
                        "vaccine",
                        "U.K.",
                        "trials"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "COVID-19 Vaccine Race Heats Up as Pfizer Gets Emergency Nod",
                "features": {
                    "keywords": [
                        "COVID-19",
                        "vaccine",
                        "Pfizer",
                        "emergency",
                        "nod"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "The Biggest Advantage and Drawback of the Most Promising Coronavirus Vaccines",
                "features": {
                    "keywords": [
                        "advantage",
                        "drawback",
                        "vaccines",
                        "coronavirus"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "The Global Energy Association: Ten key ideas in energy",
                "features": {
                    "keywords": [
                        "Global Energy",
                        "Association",
                        "key ideas",
                        "energy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "energy"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Johnson & Johnson (NYSE:JNJ) Shares Could Be 37% Below Their Intrinsic Value Estimate",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "intrinsic value",
                        "shares"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}